• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Thromb Res . Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients

tetano

Editor, Senior Moderator
Thromb Res


. 2020 Sep 15;196:308-312.
doi: 10.1016/j.thromres.2020.09.017. Online ahead of print.
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients


Romein W G Dujardin[SUP] 1 [/SUP], Bashar N Hilderink[SUP] 2 [/SUP], Wolmet E Haksteen[SUP] 3 [/SUP], S Middeldorp[SUP] 4 [/SUP], Alexander P J Vlaar[SUP] 5 [/SUP], J Thachil[SUP] 6 [/SUP], Marcella C A M?ller[SUP] 3 [/SUP], Nicole P Juffermans[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Venous thromboembolism (VTE) is a frequent complication in critically ill patients with coronavirus disease 2019 (COVID-19) and is associated with mortality. Early diagnosis and treatment of VTE is warranted.
Objective: To develop a prediction model for VTE in critically ill COVID-19 patients.
Patients and methods: In this retrospective cohort study, 127 adult patients with confirmed COVID-19 infection admitted to the intensive care unit of two teaching hospitals were included. VTE was diagnosed with either ultrasound or computed tomography scan. Univariate receiver operating characteristic (ROC) curves were constructed for Positive End Expiratory Pressure, PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio, platelet count, international normalized ratio, activated partial thromboplastin time as well as levels of fibrinogen, antithrombin, D-dimer and C-reactive protein (CRP). Multivariate analysis was done using binary linear regression.
Results: Variables associated with VTE in both univariate and multivariate analysis were D-dimer and CRP with an area under the curve (AUC) of 0.64, P = 0.023 and 0.75, P = 0.045, respectively. Variables indicating hypoxemia were not predictive. The ROC curve of D-dimer and CRP combined had an AUC of 0.83, P < 0.05. Categorized values of D-dimer and CRP were used to compute a mean absolute risk for the combination of these variables with a high positive predictive value. The predicted probability of VTE with a D-dimer > 15 in combination with a CRP > 280 was 98%. The negative predictive value of D-dimer was low.
Conclusion: Elevated CRP and D-dimer have a high positive predictive value for VTE in critically ill COVID-19 patients. We developed a prediction table with these biomarkers that can aid clinicians in the timing of imaging in patients with suspected VTE.

Keywords: C-reactive protein; COVID-19; Critical illness; D-dimer; Venous thromboembolism.
 
Back
Top Bottom